When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they c...
Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research...
Author: CNBC
Read Original Article